Reported Sep 28, 2016 · Terminated
Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD,…
Lupin Limited
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lupin Limited · 15-B, Phase 1A, Verna Industrial Area · Verna, Salcette, Goa · N/A
Is this the product you have?
Escitalopram Tablets USP 20 mg100-count bottlesRx Only
- Manufactured forLupin Pharmaceuticals, Baltimore, MD, 21202
- Manufactured byLupin Limited, Goa 403 722, India, NDC 68180-136-01
- Lot codes and dates
Lot # G510086Exp. 11/17
- Amount recalled
- 3,192 bottles (319,200 tablets)
Where it was sold
- Nationwide
Why it was recalled
Labeling: Incorrect or Missing Lot and/or Expiration Date
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lupin Limited recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.